Contact Molecules for Homologous Proteins | ||||
[Summary Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
3962048 | 317 | 38 | P02649(APOE_HUMAN) | RecName: Full=Apolipoprotein E ; Short=Apo-E;Flags: Precursor; |
QUERYSEQ |
MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEE LRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEK VQAAVGTSAAPVPSDNH |
317 | region | name | description |
1-18 | SIGNAL | ||
19-317 | CHAIN | /note="Apolipoprotein E" /id="PRO_0000001987" | |
80-101 | REPEAT | /note="1" | |
102-123 | REPEAT | /note="2" | |
124-145 | REPEAT | /note="3" | |
146-167 | REPEAT | /note="4" | |
168-189 | REPEAT | /note="5" | |
190-211 | REPEAT | /note="6" | |
212-233 | REPEAT | /note="7" | |
234-255 | REPEAT | /note="8" | |
80-255 | REGION | /note="8 X 22 AA approximate tandem repeats" | |
158-168 | REGION | /note="LDL and other lipoprotein receptors binding" ECO:0000269|PubMed:2063194" | |
210-290 | REGION | /note="Lipid-binding and lipoprotein association" ECO:0000269|PubMed:8071364" | |
266-317 | REGION | /note="Homooligomerization" | |
278-290 | REGION | /note="Specificity for association with VLDL" | |
162-165 | BINDING | /ligand="heparin" /ligand_id="ChEBI:CHEBI:28304" | |
229-236 | BINDING | /ligand="heparin" /ligand_id="ChEBI:CHEBI:28304" | |
1-317 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
317 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
2l7b | A | 98.3 | APOE_HUMAN Apolipoprotein E | ||||
2kc3 | A | 100.0 | APOE_HUMAN Apolipoprotein E | ||||
1bz4 | A | 100.0 | APOE_HUMAN PROTEIN (APOLIPOPROTEIN E) | ||||
1lpe | A | 100.0 | APOE_HUMAN APOLIPOPROTEIN E3 | ||||
1le2 | A | 99.3 | APOE_HUMAN APOLIPOPROTEIN E2 | ||||
1gs9 | A | 99.3 | APE_HUMAN APOLIPOPROTEIN E | ||||
7uvj | A | 96.5 | APOE_HUMAN Apolipoprotein E | ||||
7uvj | B | 96.5 | APOE_HUMAN Apolipoprotein E | ||||
1h7i | A | 99.3 | APE_HUMAN APOLIPOPROTEIN E | ||||
1ea8 | A | 99.3 | APE_HUMAN APOLIPOPROTEIN E | ||||
6nco | A | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
6ncn | A | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
1le4 | A | 99.3 | APOE_HUMAN APOLIPOPROTEIN E4 | ||||
8grx | C | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
8grx | A | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
1b68 | A | 99.3 | APOE_HUMAN APOLIPOPROTEIN E | ||||
7fcr | A | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
1ya9 | A | 79.2 | APOE_MOUSE Apolipoprotein E | ||||
8cdy | A | 99.3 | A0A376KDN7_ECOLX APOE_HUMAN Maltodextrin-binding protein,Apolipoprotein E | ||||
8ax9 | A | 99.3 | MALE_ECOLI APOE_HUMAN Maltose/maltodextrin-binding periplasmic protein,Apolipoprotein E | ||||
8ce0 | A | 99.3 | A0A376KDN7_ECOLX APOE_HUMAN Maltodextrin-binding protein,Apolipoprotein E | ||||
6cfe | A | 91.5 | Mutant of Apolipoprotein E3 (APO-E3) | ||||
6iwb | C | 91.6 | APOE_HUMAN Apolipoprotein E | ||||
6iwb | A | 91.5 | APOE_HUMAN Apolipoprotein E | ||||
1or3 | A | 100.0 | APOE_HUMAN PROTEIN (APOLIPOPROTEIN E) | ||||
7fcs | A | 99.3 | APOE_HUMAN Apolipoprotein E | ||||
1nfn | A | 100.0 | APOE_HUMAN APOLIPOPROTEIN E3 | ||||
1or2 | A | 100.0 | APOE_HUMAN APOLIPOPROTEIN E | ||||
1nfo | A | 98.5 | APOE_HUMAN APOLIPOPROTEIN E2 | ||||
8ax8 | A | 99.3 | MALE_ECOLI APOE_HUMAN Maltose/maltodextrin-binding periplasmic protein,Apolipoprotein E | ||||
6v7m | B | 100.0 | APOE_HUMAN Apolipoprotein E | ||||
6v7m | A | 100.0 | APOE_HUMAN Apolipoprotein E | ||||
1oef | A | 100.0 | APOE_HUMAN APOLIPOPROTEIN E | ||||
1oeg | A | 100.0 | APOE_HUMAN APOLIPOPROTEIN E | ||||
6cm1 | C | 28.5 | APOA1_HUMAN Apolipoprotein A-I | ||||
6cm1 | B | 28.5 | APOA1_HUMAN Apolipoprotein A-I | ||||
6clz | C | 28.5 | APOA1_HUMAN Apolipoprotein A-I | ||||
6clz | B | 28.5 | APOA1_HUMAN Apolipoprotein A-I | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
317 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6v7m | B | APOE_HUMAN Apolipoprotein E[83 aa] | A | 100.0 /100.0 |
28 /28 |
APOE_HUMAN Apolipoprotein E | |
6v7m | A | APOE_HUMAN Apolipoprotein E[64 aa] | B | 100.0 /100.0 |
28 /28 |
APOE_HUMAN Apolipoprotein E | |
8grx | B | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A.. | A | 100.0 /99.3 |
15 /15 |
APOE_HUMAN Apolipoprotein E | |
8grx | D | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A.. | A | 100.0 /99.3 |
8 /8 |
APOE_HUMAN Apolipoprotein E | |
8grx | B | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A.. | C | 100.0 /99.3 |
8 /8 |
APOE_HUMAN Apolipoprotein E | |
8grx | D | LIRA6_HUMAN Leukocyte immunoglobulin-like receptor subfamily A.. | C | 100.0 /99.3 |
15 /15 |
APOE_HUMAN Apolipoprotein E | |
6iwb | B | BCL2_HUMAN BCL2_HUMAN Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-.. | A | 56.0 /91.5 |
25 /25 |
APOE_HUMAN Apolipoprotein E | |
6iwb | D | BCL2_HUMAN BCL2_HUMAN Apoptosis regulator Bcl-2,Apoptosis regulator Bcl-.. | C | 60.0 /91.6 |
25 /25 |
APOE_HUMAN Apolipoprotein E | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
317 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6ncn | B |
KJM
1-(3-chlorophenyl)cyclobutane-1-carboximidamide[14.. |
A | 100.0 /99.3 |
8 /8 |
APOE_HUMAN Apolipoprotein E | |
6nco | B |
KQP
1-[5-chloro-4'-(2-hydroxypropan-2-yl)[1,1'-bipheny.. |
A | 100.0 /99.3 |
11 /11 |
APOE_HUMAN Apolipoprotein E | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
317 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
7fcr | B |
NA
SODIUM ION[1 atoms] |
A | 100.0 /99.3 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
7fcr | C |
NA
SODIUM ION[1 atoms] |
A | 100.0 /99.3 |
5 /5 |
APOE_HUMAN Apolipoprotein E | |
7fcs | B |
NA
SODIUM ION[1 atoms] |
A | 100.0 /99.3 |
3 /3 |
APOE_HUMAN Apolipoprotein E | |
7fcs | C |
NA
SODIUM ION[1 atoms] |
A | 100.0 /99.3 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
7fcs | D |
NA
SODIUM ION[1 atoms] |
A | 100.0 /99.3 |
5 /5 |
APOE_HUMAN Apolipoprotein E | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
317 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6clz | C | APOA1_HUMAN Apolipoprotein A-I[211 aa] | B | 28.9 /28.5 |
38 /49 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | B | APOA1_HUMAN Apolipoprotein A-I[211 aa] | C | 28.2 /28.5 |
39 /47 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | C | APOA1_HUMAN Apolipoprotein A-I[211 aa] | B | 29.8 /28.5 |
47 /57 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | B | APOA1_HUMAN Apolipoprotein A-I[211 aa] | C | 29.2 /28.5 |
48 /58 |
APOA1_HUMAN Apolipoprotein A-I | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
317 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
6v7m | C |
PO4
PHOSPHATE ION[5 atoms] |
A | 100.0 /100.0 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
6v7m | C |
PO4
PHOSPHATE ION[5 atoms] |
B | 100.0 /100.0 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
7uvj | C |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /96.5 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
7uvj | F |
GOL
GLYCEROL[6 atoms] |
B | 100.0 /96.5 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
8ce0 | B |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /99.3 |
5 /5 |
A0A376KDN7_ECOLX APOE_HUMAN Maltodextrin-binding protein,Apolipoprotein E | |
7uvj | D |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /96.5 |
3 /3 |
APOE_HUMAN Apolipoprotein E | |
7uvj | G |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 100.0 /96.5 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
7uvj | E |
ACT
ACETATE ION[4 atoms] |
A | 100.0 /96.5 |
1 /1 |
APOE_HUMAN Apolipoprotein E | |
6iwb | E |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /91.5 |
3 /3 |
APOE_HUMAN Apolipoprotein E | |
6iwb | F |
SO4
SULFATE ION[5 atoms] |
A | 50.0 /91.5 |
2 /2 |
APOE_HUMAN Apolipoprotein E | |
6clz | BB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
7 /7 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CD |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | EB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | EC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | GB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | GC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | GD |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | HB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | HC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | IB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | KB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | KF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | LB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | MB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
8 /9 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | MF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | NB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 40.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | OB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | PB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | PC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | QF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 66.7 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | RB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 66.7 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SE |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | TB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | TE |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | UB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | UF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | VB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 20.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | WB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | XB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | BB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | CG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | DG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | EB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | EF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | EG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
2 /6 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 80.0 /28.5 |
5 /6 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | FG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 75.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | GC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | GF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | HC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | HF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
8 /8 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | IB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | JF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | KB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | KF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | LB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | MF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | OB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | OF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | OG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | PF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | QF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SE |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | SG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | TB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | TE |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | TF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | UB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | UF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
6 /6 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | VF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 71.4 /28.5 |
7 /7 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | WB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | WF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | XB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | XF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6clz | YF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | AC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | BC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 20.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | CC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | DC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | EG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | GG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | HB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | IB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | IC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | IF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | JB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | JF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KD |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | LB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 20.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | LC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
2 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | MB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | MC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 50.0 /28.5 |
6 /7 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | NB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 66.7 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | NC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | OB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | OF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | PB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 66.7 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | QB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | QF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | RB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | RC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | RF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | SF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | TB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | UB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | VB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | WF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | XB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | YB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 66.7 /28.5 |
3 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | ZB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | ZF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
B | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | AG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | BG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 40.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | CG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 16.7 /28.5 |
6 /6 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | DC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | DF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | DG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | GF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | GG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | HF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | IC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | IF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | JB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | JF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | JG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | KG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | LF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | MC |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | MF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | NB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | NF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | OB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | OF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | OG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | PB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | QF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | RF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | SF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | SG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | TF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 33.3 /28.5 |
3 /3 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | UB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | UF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | VB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 100.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | WF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 50.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | XF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
2 /2 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | XG |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | YF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 25.0 /28.5 |
4 /4 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | ZB |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 0.0 /28.5 |
1 /1 |
APOA1_HUMAN Apolipoprotein A-I | |
6cm1 | ZF |
PX4
1,2-DIMYRISTOYL-SN-GLYCERO-3-PHOSPHOCHOLINE[46 ato.. |
C | 20.0 /28.5 |
5 /5 |
APOA1_HUMAN Apolipoprotein A-I | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |